Acucela Inc (DBA Kubota Vision Inc.) Revenue and Competitors

Seattle, WA USA

Location

$0.44M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Acucela Inc (DBA Kubota Vision Inc.)'s estimated annual revenue is currently $2.2M per year.(i)
  • Acucela Inc (DBA Kubota Vision Inc.)'s estimated revenue per employee is $77,500
  • Acucela Inc (DBA Kubota Vision Inc.)'s total funding is $0.44M.

Employee Data

  • Acucela Inc (DBA Kubota Vision Inc.) has 29 Employees.(i)
  • Acucela Inc (DBA Kubota Vision Inc.) grew their employee count by -9% last year.

Acucela Inc (DBA Kubota Vision Inc.)'s People

NameTitleEmail/Phone
1
VP Clinical Development and Medical AffairsReveal Email/Phone
2
Chief Commercial OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Clinical Trial ManagerReveal Email/Phone
5
CEO/ Chairman/PresidentReveal Email/Phone
6
Senior Payroll & A/P SpecialistReveal Email/Phone
7
Communications CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Acucela Inc (DBA Kubota Vision Inc.)?

Acucela Inc. is a clinical stage biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt\'s disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people worldwide, and there is a drastic lack of therapies available. Until now, ophthalmic drug discovery technologies have been very limited.

keywords:N/A

$0.44M

Total Funding

29

Number of Employees

$2.2M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Acucela Inc (DBA Kubota Vision Inc.) News

2012-06-12 - Acucela, Turning 10, Gears Up for Pivotal Test With Eye Drug

Share Share on Facebook Share on Twitter LinkedIn Email Reprints Any one of a thousand little decisions can trip up an experimental drug on its long journey to the marketplace. Now, after 10 years in business, Seattle-based Acucela will be making a lot of important decisions that will determine ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M2926%N/A
#2
$3.3M29-9%$72.5M
#3
$4.5M294%N/A
#4
$2.9M29-41%N/A
#5
$5.5M29-33%N/A